Evidence map›Paper›PMID 35964413›Full record

ArticleInternational immunopharmacology2022

IL-6 drives T cell death to participate in lymphopenia in COVID-19.

Xiaoqi Zhou, Guangming Ye, Yibing Lv, Yanyan Guo, Xingfei Pan, Yirong Li, Guanxin Shen, Yong He, Ping Lei

Open access · greenAbstract read
In one paragraph

Article in International immunopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xiaoqi ZhouDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Nuclear Medicine and PET Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Guangming YeDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yibing LvDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yanyan GuoDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xingfei PanDepartment of Infectious Diseases, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yirong LiDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Guanxin ShenDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yong HeDepartment of Nuclear Medicine and PET Center, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: heyong@znhospital.cn.
Ping LeiDepartment of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: adaleip@hust.edu.cn.
Huazhong University of Science and Technology · CNWuhan University · CNThird Affiliated Hospital of Guangzhou Medical University · CNZhongnan Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphopenia is a common observation in patients with COVID-19. To explore the cause of T cell lymphopenia in the disease, laboratory results of 64 hospitalized COVID-19 patients were retrospectively analyzed and six patients were randomly selected to trace their changes of T lymphocytes and plasma concentration of IL-6 for the course of disease. Results confirmed that the T-cell lymphopenia, especially CD4

Indexed as

COVID-19LymphopeniaCell DeathHumansInterleukin-6Retrospective StudiesSARS-CoV-2T-LymphocytesInterleukin-6COVID-19ICU careIL-6LymphopeniaSARS-CoV-2

Identifiers

PMID35964413
PMCPMC9359506
OpenAlexW4291170378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.